Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation

Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation

Purpose: Chemoradiation (CRT) is a definitive treatment option for muscle-invasive bladder cancer (MIBC). Despite its effectiveness, CRT is underused, in part owing to concerns of tolerability and the need for integrated multidisciplinary care. We investigated factors associated with and the impact...

Full description

Bibliographic Details
Main Authors: Nikhil V. Kotha, BS, Abhishek Kumar, MD, MAS, Tyler J. Nelson, BS, Edmund M. Qiao, BS, Alex S. Qian, BS, Rohith S. Voora, BS, Rana R. McKay, MD, Tyler F. Stewart, MD, Brent S. Rose, MD
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109421001949

Internet

http://www.sciencedirect.com/science/article/pii/S2452109421001949

Similar Items